Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment-Reference-Cited by-同舟云学术

Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment

Published:2012-01 Issue:S1 Volume:52 Page:
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Hariharan Sudharshan¹,Madabushi Rajanikanth¹

Affiliation:

1. Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/0091270011415527

Reference16 articles.

1. Boehringer Ingelheim Pharmaceuticals Inc.Advisory committee briefing document[page42]. Available at:http:www.fda.govdownloadsAdvisoryCommitteesCommitteesMeetingMaterialsDrugsCardiovascularandRenalDrugsAdvisoryCommitteeUCM226009.pdf. Accessed March 11 2011.

2. Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease

3. Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)

4. HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Platelet Dysfunction and End-Stage Renal Disease

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescription of DOACs in Patients with Atrial Fibrillation at Different Stages of Renal Insufficiency;Advances in Therapy;2023-08-18

2. Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant;IJC Heart & Vasculature;2022-12

3. Pharmacokinetic modeling and simulation of subcutaneous and intravenous IgG dosing in patients with primary immunodeficiency diseases;International Immunopharmacology;2022-03

4. Systemic Anticoagulation and Reversal;Surgical Clinics of North America;2022-02

5. Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism: Use in Patients with Advanced Renal Impairment, Obesity, or Other Weight-Related Special Populations;Seminars in Respiratory and Critical Care Medicine;2021-02-18